[Federal Register Volume 78, Number 141 (Tuesday, July 23, 2013)]
[Notices]
[Page 44136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-17644]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB review; 30-day Comment Request: National 
Cancer Institute (NCI) Cancer Nanotechnology Platform Partnership 
Scientific Progress Reports

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH), has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval of the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register on May 13, Vol. 78, p. 27974 and allowed 60-days for public 
comment. No public comments were received. The purpose of this notice 
is to allow an additional 30 days for public comment. The National 
Cancer Institute (NCI), National Institutes of Health, may not conduct 
or sponsor, and the respondent is not required to respond to, an 
information collection that has been extended, revised, or implemented 
on or after October 1, 1995, unless it displays a currently valid OMB 
control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.
    For Further Information: To obtain a copy of the data collection 
plans and instruments or request more information on the proposed 
project contact: Dorothy Farrell, Center for Strategic Scientific 
Initiatives, Office of Cancer Nanotechnology Research, National Cancer 
Institute, 31 Center Drive, Bldg. 31 A, Rm. 10A52, Bethesda, MD 20892 
or call non-toll-free number 301-496-5652 or Email your request, 
including your address to: [email protected]. Formal requests for 
additional plans and instruments must be requested in writing.
    Proposed Collection: National Cancer Institute (NCI) Alliance for 
Nanotechnology in Cancer Platform Partnership Scientific Progress 
Reports, 0925-NEW, National Cancer Institute (NCI), National Institutes 
of Health (NIH).
    Need and Use of Information Collection: National Institutes of 
Health grantees are required to submit interim and final progress 
reports and other post-award documents associated with the monitoring, 
oversight, and closeout of an award. This submission represents a 
request for OMB to approve new program specific progress report 
guidelines for Cancer Nanotechnology Platform Partnerships (CNPP) 
awarded by the National Cancer Institute (NCI). The CNPPs are part of 
the Alliance for Nanotechnology in Cancer, a network of awards funded 
by NCI to promote the application of nanotechnology to cancer research 
and care. The proposed guidelines request information about award 
performance related to trans-Alliance collaboration, scientific 
milestones, progress towards clinical translation and technology 
commercialization, and education and outreach efforts. The report also 
gathers information on leveraged funding, patents and publications. The 
information is gathered every six months. This information is needed to 
monitor the performance of this special program within NCI, funded 
through Requests for Applications (RFA CA-09-013, released May 29, 
2009) using the cooperative agreement mechanism (U01). The information 
will be used to monitor individual award performance and the 
effectiveness of the program as a whole. The respondents are the 
Principal Investigators of the awards, along with their institutional 
business officials. The awards are administered by and the reports 
reviewed by the Office of Cancer Nanotechnology Research (OCNR), part 
of the Center for Strategic Scientific Initiatives within NCI.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The estimated annualized burden 
hours are 72.

                                        Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
                                                                  Number of     Average  burden
         Type of  respondent           Number of  respondents   responses per    per  response     Total annual
                                                                  respondent       (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
Principal Investigators.............  12.....................               2                3               72
----------------------------------------------------------------------------------------------------------------


    Dated: July 15, 2013.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2013-17644 Filed 7-22-13; 8:45 am]
BILLING CODE 4140-01-P